Related Experiment Videos
Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus
Stéphan Chabardès1, Philippe Kahane, Lorella Minotti
1Neurosurgery Department, CHU Michallon, BP 217 X, 38043 Grenoble Cedex, France. SChabardes@chu-grenoble.fr
Epileptic Disorders : International Epilepsy Journal with Videotape
|December 24, 2002
Summary
High-frequency stimulation of the subthalamic nucleus (STN HFS) shows promise for treating drug-resistant epilepsy in patients ineligible for surgery. Some patients experienced significant seizure reduction, indicating STN HFS as a potential therapeutic option.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Medically refractory epilepsy poses challenges for patients unsuitable for resective surgery.
- Alternative treatments like deep brain neurostimulation are under investigation.
- Previous studies explored STN inhibition in animal models and STN HFS for movement disorders.
Purpose of the Study:
- To evaluate the efficacy of high-frequency stimulation of the subthalamic nucleus (STN HFS) in patients with medically intractable epilepsy.
- To determine if STN HFS is a viable alternative for patients ineligible for conventional epilepsy surgery.
Main Methods:
- Five patients with medically intractable epilepsy, unsuitable for resective surgery, underwent STN HFS.
- Seizure frequency was monitored before and after the intervention.
Main Results:
- Three patients with partial symptomatic epilepsy showed a 67%-80% reduction in seizure frequency.
- One patient with Dravet syndrome experienced a weaker seizure reduction.
- One patient with autosomal dominant frontal lobe epilepsy showed no improvement.
Conclusions:
- STN HFS demonstrates potential as a therapeutic option for specific cases of drug-resistant epilepsy.
- Patient selection is crucial, as not all epilepsy types respond to STN HFS.
- Further research is warranted to optimize STN HFS for refractory epilepsy treatment.